These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21321393)

  • 1. Antibodies against extracellular domains of α4 and α7 subunits alter the levels of nicotinic receptors in the mouse brain and affect memory: possible relevance to Alzheimer's pathology.
    Lykhmus O; Koval L; Skok M; Zouridakis M; Zisimopoulou P; Tzartos S; Tsetlin V; Granon S; Changeux JP; Komisarenko S; Cloëz-Tayarani I
    J Alzheimers Dis; 2011; 24(4):693-704. PubMed ID: 21321393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence and origin of autoantibodies against α4 and α7 nicotinic acetylcholine receptors in the human blood: possible relevance to Alzheimer's pathology.
    Koval L; Lykhmus O; Kalashnyk O; Bachinskaya N; Kravtsova G; Soldatkina M; Zouridakis M; Stergiou C; Tzartos S; Tsetlin V; Komisarenko S; Skok M
    J Alzheimers Dis; 2011; 25(4):747-61. PubMed ID: 21593571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid β42 accumulation in the mouse brain to impair memory.
    Lykhmus O; Voytenko L; Koval L; Mykhalskiy S; Kholin V; Peschana K; Zouridakis M; Tzartos S; Komisarenko S; Skok M
    PLoS One; 2015; 10(3):e0122706. PubMed ID: 25816313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of antibodies against non-neuronal nicotinic acetylcholine receptors.
    Lykhmus O; Koval L; Pavlovych S; Zouridakis M; Zisimopoulou P; Tzartos S; Tsetlin V; Volpina O; Cloëz-Tayarani I; Komisarenko S; Skok M
    Immunol Lett; 2010 Jan; 128(1):68-73. PubMed ID: 19931311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
    Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of carbohydrate component of recombinant α7 nicotinic acetylcholine receptor extracellular domain in its immunogenicity and functional effects of resulting antibodies.
    Lykhmus O; Koval L; Pastuhova D; Zouridakis M; Tzartos S; Komisarenko S; Skok M
    Immunobiology; 2016 Dec; 221(12):1355-1361. PubMed ID: 27498631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42).
    Xiu J; Nordberg A; Zhang JT; Guan ZZ
    Neurochem Int; 2005 Sep; 47(4):281-90. PubMed ID: 15955596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Stearoylethanolamine protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of α7 nicotinic acetylcholine receptor.
    Lykhmus O; Uspenska K; Koval L; Lytovchenko D; Voytenko L; Horid'ko T; Kosiakova H; Gula N; Komisarenko S; Skok M
    Int Immunopharmacol; 2017 Nov; 52():290-296. PubMed ID: 28963942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic acetylcholine receptors alpha4beta2 and alpha7 regulate myelo- and erythropoiesis within the bone marrow.
    Koval LM; Zverkova AS; Grailhe R; Utkin YN; Tsetlin VI; Komisarenko SV; Skok MV
    Int J Biochem Cell Biol; 2008; 40(5):980-90. PubMed ID: 18083057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of neuronal nicotinic acetylcholine receptors containing different alpha-subunits in the submucosal plexus of the guinea-pig.
    Glushakov AV; Voytenko LP; Skok MV; Skok V
    Auton Neurosci; 2004 Jan; 110(1):19-26. PubMed ID: 14766321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells or Interleukin-6 Improve Episodic Memory of Mice Lacking α7 Nicotinic Acetylcholine Receptors.
    Lykhmus O; Kalashnyk O; Koval L; Voytenko L; Uspenska K; Komisarenko S; Deryabina O; Shuvalova N; Kordium V; Ustymenko A; Kyryk V; Skok M
    Neuroscience; 2019 Aug; 413():31-44. PubMed ID: 31202708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic alterations of gene expression of nicotinic acetylcholine receptor α7, α4 and β2 subunits in an acute MPTP-lesioned mouse model.
    Hu J; Zhu C; Liu Y; Wang F; Huang Z; Fan W; Wu J
    Neurosci Lett; 2011 May; 494(3):232-6. PubMed ID: 21406211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
    Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
    Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.